» Articles » PMID: 26528137

Basal Adenosine Modulates the Functional Properties of AMPA Receptors in Mouse Hippocampal Neurons Through the Activation of A1R A2AR and A3R

Overview
Specialty Cell Biology
Date 2015 Nov 4
PMID 26528137
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Adenosine is a widespread neuromodulator within the CNS and its extracellular level is increased during hypoxia or intense synaptic activity, modulating pre- and postsynaptic sites. We studied the neuromodulatory action of adenosine on glutamatergic currents in the hippocampus, showing that activation of multiple adenosine receptors (ARs) by basal adenosine impacts postsynaptic site. Specifically, the stimulation of both A1R and A3R reduces AMPA currents, while A2AR has an opposite potentiating effect. The effect of ARs stimulation on glutamatergic currents in hippocampal cultures was investigated using pharmacological and genetic approaches. A3R inhibition by MRS1523 increased GluR1-Ser845 phosphorylation and potentiated AMPA current amplitude, increasing the apparent affinity for the agonist. A similar effect was observed blocking A1R with DPCPX or by genetic deletion of either A3R or A1R. Conversely, impairment of A2AR reduced AMPA currents, and decreased agonist sensitivity. Consistently, in hippocampal slices, ARs activation by AR agonist NECA modulated glutamatergic current amplitude evoked by AMPA application or afferent fiber stimulation. Opposite effects of AR subtypes stimulation are likely associated to changes in GluR1 phosphorylation and represent a novel mechanism of physiological modulation of glutamatergic transmission by adenosine, likely acting in normal conditions in the brain, depending on the level of extracellular adenosine and the distribution of AR subtypes.

Citing Articles

Inhibition of ADORA3 promotes microglial phagocytosis and alleviates chronic ischemic white matter injury.

Xu Y, Tang L, Zhou C, Sun L, Hu Y, Zhang Z CNS Neurosci Ther. 2024; 30(5):e14742.

PMID: 38715283 PMC: 11076989. DOI: 10.1111/cns.14742.


Cortical spreading depression can be triggered by sensory stimulation in primed wild type mouse brain: a mechanistic insight to migraine aura generation.

Hanalioglu S, Taskiran-Sag A, Karatas H, Donmez-Demir B, Yilmaz-Ozcan S, Eren-Kocak E J Headache Pain. 2022; 23(1):107.

PMID: 35986251 PMC: 9392331. DOI: 10.1186/s10194-022-01474-0.


Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A Antagonists.

Val C, Rodriguez-Garcia C, Prieto-Diaz R, Crespo A, Azuaje J, Carbajales C J Med Chem. 2022; 65(3):2091-2106.

PMID: 35068155 PMC: 8842224. DOI: 10.1021/acs.jmedchem.1c01636.


Pharmacological characterization of DPTN and other selective A adenosine receptor antagonists.

Gao Z, Suresh R, Jacobson K Purinergic Signal. 2021; 17(4):737-746.

PMID: 34713378 PMC: 8677861. DOI: 10.1007/s11302-021-09823-5.


Emerging roles of dysregulated adenosine homeostasis in brain disorders with a specific focus on neurodegenerative diseases.

Chang C, Wu K, Lin C, Chern Y J Biomed Sci. 2021; 28(1):70.

PMID: 34635103 PMC: 8507231. DOI: 10.1186/s12929-021-00766-y.


References
1.
Franco R, Casado V, Ciruela F, Saura C, Mallol J, Canela E . Cell surface adenosine deaminase: much more than an ectoenzyme. Prog Neurobiol. 1997; 52(4):283-94. DOI: 10.1016/s0301-0082(97)00013-0. View

2.
Salvatore C, Tilley S, Latour A, Fletcher D, Koller B, Jacobson M . Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells. J Biol Chem. 2000; 275(6):4429-34. DOI: 10.1074/jbc.275.6.4429. View

3.
Eckstein F . Nucleoside phosphorothioates. Annu Rev Biochem. 1985; 54:367-402. DOI: 10.1146/annurev.bi.54.070185.002055. View

4.
Banke T, Bowie D, Lee H, Huganir R, Schousboe A, Traynelis S . Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase. J Neurosci. 2000; 20(1):89-102. PMC: 6774102. View

5.
Boison D, Chen J, Fredholm B . Adenosine signaling and function in glial cells. Cell Death Differ. 2009; 17(7):1071-82. PMC: 2885470. DOI: 10.1038/cdd.2009.131. View